Last updated on September 2018

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

Brief description of study

A clinical research study called 'POINT' will evaluate if adding an oral study drug to Tecfidera® can have an effect on multiple sclerosis (MS) disease activity.

In this study, patients with active relapsing MS will receive add-on therapy with ponesimod (a sphingosine 1-phosphate [S1P] receptor modulator) or placebo on top of background treatment with another oral MS drug (dimethyl fumarate [DMF] - Tecfidera®).

Eligible participants must currently take Tecfidera® and have taken this medication for at least 6 months. The primary objective of the study is to determine whether add-on therapy with ponesimod reduces relapse frequency as compared to placebo in subjects with active relapsing MS who are treated with Tecfidera®.

Clinical Study Identifier: TX203815

Find a site near you

Start Over

UAB Dpt of Neurology

Birmingham, AL United States
  Connect »

Care Access Research - Santa Clarita

Santa Clarita, CA United States
  Connect »

Tallahassee Neurological Clinic

Tallahassee, FL United States
  Connect »

University of Kansas Med Center

Kansas City, KS United States
  Connect »

Riverhills Healthcare, Inc.

Cincinnati, OH United States
  Connect »

Neurology Center of San Antonio

San Antonio, TX United States
  Connect »

Neuro-Pain Medical Center

Fresno, CA United States
  Connect »

Associated Neurologists

Danbury, CT United States
  Connect »

Florida Academic Research, LLC

Boca Raton, FL United States
  Connect »

University of Alberta

Located in Edmonton, Alberta Canada
  Connect »

Mehiläinen NEO

Located in Turku, Finland
  Connect »

Terveystalo Tampere

Located in Tampere, Finland
  Connect »

Advanced Neurosciences Institute

Located in Franklin, TN United States
  Connect »

Neurology and Neuromuscular Center

Located in: Oklahoma City, OK USA
  Connect »

Bradenton Research Center

Located in: Bradenton, FL USA
  Connect »